Double selective synthetic approach to the n-functionalized 1,4,7-triazacyclononane derivatives: chelating compounds for controllable protein orientation

Journal of Organic Chemistry

Volumn 75, Issue 6, 2010, Pages 2069-2072

  Sobieściak, Tomasz D ^a   Zielenkiewicz, Piotr ^a  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING COMPOUND; CHEMICAL EQUATIONS; FUNCTIONALIZATIONS; FUNCTIONALIZED; HISTIDINE-TAGGED PROTEINS; NANO PATTERN; PENDANT ARMS; PROTEIN ORIENTATION; SYNTHETIC APPROACH; SYNTHETIC ROUTES; TRIAZACYCLONONANE;

CHELATION; MONOLAYERS; PHOSPHATASES;

PROTEINS;

1,4,7 TRIAZACYCLONONANE DERIVATIVE; CHELATING AGENT; NITROGEN; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CHEMICAL STRUCTURE; PROTEIN SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

CHELATING AGENTS; ENZYMES, IMMOBILIZED; HETEROCYCLIC COMPOUNDS; LIGANDS; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEINS; SURFACE PROPERTIES;

EID: 77949808929     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo902504d     Document Type: Article

References (87)

1. (a) Monti, M.; Cozzolino, M.; Cozzolino, F.; Vitiello, G.; Tedesco, R.; Flagiello, A.; Pucci, P. Expert Rev. Proteomics 2009, 6, 159-169.
2. (b) Fuentes, G.; Oyarzabal, J.; Rojas, A. M. Curr. Opin. Drug Discovery Dev. 2009, 12, 358-366.
3. (c) Piehler, J. Curr. Opin. Struct. Biol. 2005, 15, 4-14.
4. (d) Lee, H.J.; Yan, Y.; Marriott, G.; Corn. R. M. J. Physiol. 2005, 563, 61-71.
5. Rusmini, F.; Zhong, Z.; Feijen, J. Biomacromolecules 2007, 8, 1775-1789.
6. Sigal, G. B.; Bamdad, C.; Barberis, A.; Strominger, J.; Whitesides, G. M. Anal. Chem. 1996, 68, 490-497.
7. (a) Ulman, A. Chem. Rev. 1996, 96, 1533-1554.
8. (b) Senaratne, W.; Andruzzi, L.; Ober, C. K. Biomacromolecules 2005, 6, 2427-2448.
9. (a) Yeo, W.-S.; Mm, D.-H.; Hsieh, R. W.; Greene, G. L.; Mrksich, M. Angew. Chem. Int. Ed. 2005, 44, 5480-5483.
10. (b) Fukuzawa, S.; Asanuma, M.; Tachibana, K.; Hirota, H. J. Mass. Spectrom. Soc. Jpn. 2006, 54, 187-193.
11. Oligo(ethylene glycol) (OEG) is also referred to as oligo(oxyethylene), oligo(ethylene oxide).
12. Prime, K. L.; Whitesides, G. M. Science 1991, 252, 1164-1167.
13. (a) Gamsjaeger, R.; Wimmer, B.; Kahr, H.; Tinazli, A.; Picuric, S.; Lata, S.; Tampé, R.; Maulet, Y.; Gruber, H. J.; Hinterdorfer, P.; Romanin, C. Langmuir 2004, 20, 5885-5890.
14. (b) Merkel, J. S.; Michaud, G. A.; Salcius, M.; Schweitzer, B.; Predki, P. F. Curr. Opin. Biotechnol. 2005, 16, 447-452.
15. (c) Cha, T.; Guo, A.; Zhu, X.-Y. Proteomics 2005, 5, 416-419.
16. (a) Crowe, J.; Döbeli, H.; Gentz, R.; Hochuli, E.; Stüber, D.; Heneo, K. Methods Mol. Biol. 1994, 31, 371-387.
17. (b) Derewenda, Z. S. Method, 2004, 34, 354-363.
18. (a) Nieba, L.; Nieba-Axmann, S. E.; Persson, A.; Hämälä inen, M.; Edebratt, F.; Hansson, A.; Lidholm, J.; Magnusson, K.; Karlsson, A. F.; Plückthun, A. Anal. Biochem. 1997, 252, 217-228.
19. (b) Lata, S.; Reichel, A.; Brock, R.; Tampé, R.; Piehler, J. J. Am. Chem. Soc. 2005, 127, 10205-10215.
20. Valiokas, R.; Kienkar, G.; Tinazli, A.; Reichel, A.; Tampe, R.; Piehler, J.; Liedberg, B. Langmuir 2008, 24, 4959-4967.
21. Johnson, D. L.; Martin, L. L. J. Am. Chem. Soc. 2005, 127, 2018-2019.
22. Jiang, W.; Prescott, M.; Devenish, R. J.; Spiccia, L.; Hearn, M. T. W. Biotechnol. Bioeng. 2009, 103, 747-756.
23. Marin, V. L.; Bayburt, T. H.; Silgar, S. G.; Mrksich, M. Angew. Chem. Int. Ed. 2007, 46, 8796-8798.
24. Bain, C. D.; Biebuyck, H. A.; Whitesides, G. M. Langmuir 1989, 5, 723-727.
25. (a) Wagner, P.; Hegner, M.; Kernen, P.; Zaugg, F.; Semenza, G. Biophys. J. 1996, 70, 2052-2066.
26. (b) Laurent, N.; Voglmeir, J.; Wright, A.; Blackburn, J.; Pham, N. T.; Wong, S. C. C.; Gaskell, S. J.; Flitseh, S. L. Chem. BioChem 2008, 9, 883-887.
27. Tournier, E. J. M.; Wallach, J.; Blond, P. Anal. Chim. Acta 1998, 361, 33-44.
28. Luk, Y.-Y.; Tingey, M. L.; Hall, D. J.; Israel, B. A.; Murphy, C. J.; Bertics, P. J.; Abbott, N. L. Langmuir 2003, 19, 1671-1680.
29. (a) Yang, R.; Zompa, L. J. Inorg, Chem. 1976, 15, 1499-1502.
30. (b) Wainwright, K. P. Coord. Chem. Rev. 1997, 166, 35-90.
31. (a) Kovacs, Z.; Sherry, A. D. Tetrahedron Lett. 1995, 36, 9269-9272.
32. (b) Pulacchini, S.; Watkinson, M. Tetrahedron Lett. 1999, 40, 9363-9365.
33. (c) Ellis, D.; Farrugia, L. J.; Peacock. R. D. Polyhedron 1999, 18, 1229-1234.
34. (d) Biot, C.; Dessolin, J.; Ricard, I.; Dive, D. J. Organomet. Chem. 2004, 689, 4678-4682.
35. Nonat, A.; Gateau, C.; Fries, P. H.; Mazzanti, M. Chem.-Eur. J. 2006, 12, 7133-7150.
36. (a) Weisman, G. R.; Vachon, D. J.; Johnson, V. B.; Gronbeck, D. A. J. Chem. Soc. Chem. Commun. 1987, 12, 886-887.
37. (b) Alder, R. W.; Mowlam, R. W.; Vachon, D. J.; Weisman, G. R. J. Chem. Soc. Chem. Commun. 1992, 6, 507-508.
38. (c) Schulz, D.; Weyhermülier, T.; Wieghardt, K.; Nuber, B. Inorg. Chim. Acta 1995, 240, 217-229.
39. (d) Stockheim, C.; Hoster, L.; Weyhermülier, T.; Wieghardt, K.; Nuber, B. J. Chem. Soc. Dalton Trans. 1996, 23, 4409-4416.
40. (e) Blake, A. J.; Fallis, I. A.; Gould, R. O.; Parsons, S.; Ross, S. A.; Schröder, M. J. Chem. Soc. Dalton Trans. 1996, 4379-4387.
41. For example: (a) Ellis, D.; Farrugia, L. J.; Hickman, D. T.; Lovatt, P. A.; Peacock, R. D. Chem. Commun. 1996, 15, 1817-1818.
42. (b) Blake, A. J.; Fallis, I. A.; Heppeler, A.; Parsons, S.; Ross, S. A.; Schröder, M. J. Chem. Soc. Dalton Trans. 1996, 1, 31-43.
43. (c) Creaser, S. P.; Lincoln, S. F.; Pyke, S. M. J. Chem. Soc. Perkin Trans. 1 1999, 9, 1211-1213.
44. (d) McGowan, P. C.; Podesta. T. J.; Thornton-Pett, M. Inorg. Chem. 2001, 40, 1445-1453.
45. (a) Warden, A.; Graham, B.; Hearn, M. T. W.; Spiccia, L. Org. Lett. 2001, 3, 2855-2858.
46. (b) Belousoff, M. J.; Battle, A. R.; Graham, B.; Spiccia, L. Polyhedron 2007, 26, 344-355.
47. (a) For example: Pale-Grosdemange, C.; Simon, E. S.; Prime, K. L.; Whitesides, G. M. J. Am. Chem. Soc. 1991, 113, 12-20.
48. (b) For example: Hoffmann, Ch.; Tovar. G. E. M. J. Colloid Interface Sci. 2006, 295, 427-435.
49. (c) Yam, C. M.; Lopez-Romero, J. M.; Gu, J.; Cai, C. Chem. Commun. 2004, 2510-2511.
50. (d) Lasseter, T. L.; Clare, B. H.; Abbott, N. L.; Hamers, R. J. J. Am. Chem. Soc. 2004, 126, 10220-10221.
51. Richman, J. E.; Atkins, T. J. J. Am. Chem. Soc. 1974, 96, 2268-2270.
52. Atkins, T. J. J. Am. Chem. Soc. 1980, 102, 6364-6365.
53. Xu, D.; Prasad, k.; Repic, O.; Blacklock, T. J. Tetrahedron Lett. 1995, 36, 7357-7360.
54. 1H NMR spectrum indicates that 7a is still present (5.3 (br s, CONH)). The deprotection of the N-trifluoroacetyl group with 1M NaOH was sluggish; see: Rosso, V. W.; Pazdan, J. L.; Venit, J. J. Org. Proc. Res. Dev. 2001, 5, 294-298.
55. For example: (a) Calm̀s, M.; Escale, F.; Rolland, M.; Martinez, J. Tetrahedron: Asymmetry 2003, 14, 1685-1689.
56. (b) Boger, D. L.; Yohannes, D. J. Org. Chem. 1989, 54, 2498-2502.
57. (c) Jackson, R. F. W.; Rilatt, I.; Murray, P. J. Chem. Commun. 2003, 1242-1243.
58. (d) Weygand, F.; Frauendorfer, E. Chem. Ber. 1970, 103, 2437-2449.
59. (a) Seki, H.; Koga, K.; Matsuo, H.; Ohki, S.; Matsuo, I.; Yamada, S-i. Chem Pharm Bull. 1965, 13, 995-1000.
60. (b) Brown, M. S.; Rapoport, H. J. Org. Chem. 1998, 28, 3261-3263.
61. Kaestle, K. L.; Anwer, M. K.; Audhya, T. K.; Goldstein, G. Tetrahedron Lett. 1991, 32, 327-330.
62. 2O; see ref 30c.
63. 2O/MeOH (see ref 30b). Nonetheless, Kudzin et al. reported, that NaOMe-mediated deprotection is not effective due to the formation of stable amidate salts; see: Kudzin, Z. H.; Łyźwa, P.; Łuczak, J.; Andrijewski, G. Synthesis 1997, 44-46.
64. Schultz, R. A.; White, B. D.; Dishong, D. M.; Arnold, K. A.; Gokel, G. W. J. Am. Chem. Soc. 1985, 107, 6659-6668.
65. In NMR spectra characteristic peaks are observed (see the Supporting Information).
66. The structure of this compound, was analyzed by 2D NMR, IR, and ESI-MS as well (see the Supporting Information).
67. Geiger, R.; Siedel, W. Chem. Ber. 1968, 101, 3386-3391.
68. The structure of this compound was analyzed by 2D NMR, IR, and ESI-MS as well (see the Supporting Information).
69. Reddy, P. G.; Kumar, G. D. K.; Baskaran, S. Tetrahedron Lett. 2000, 41, 9149-9151.
70. (a) The structure of this compound was analyzed by 2D NMR, IR, and ESI-MS as well (see the Supporting Information.
71. (b) The "tacn"-OEG-alkene was further thioacetylated (AcSH, AIBN). Subsequent smooth deprotection of formyl and acetyl groups was performed under acidic conditions (see the Supporting Information).
72. Stewart, W. E.; Siddall, T. H. Chem. Rev. 1970, 70, 517-551.
73. (a) Suarez, C.; Nicholas, E. J.; Bowman, M. R. J. Phys. Chem. A 2003, 107, 3024-3029.
74. (b) Graham, L. L. Org., Magn. Reson. 1971, 4, 335-342.
75. (c) Massey, A. P.; Sigurdsson, S. Th. Nucleic Acids Res. 2004, 32, 2017-2022.
76. Smith, B. D.; Goodenough-Lashua, D. M.; D'Souza, C. J. E.; Norton, K. J.; Schmidt, L. M.; Tung, J. C. Tetrahedron Lett. 2004, 45, 2747-2749.
77. Kleinpeter, E.; Holzberger, A. Tetrahedron 2006, 62, 10237-10247.
78. Benniston, A. C.; Gunning, P.; Peacock, R. D. J. Org. Chem. 2005, 70, 115-123.
79. Sessler, J. L.; Sibert, J. W.; Burrell, A. K.; Lynch, V.; Markert, J. T.; Wooten, C. L. Inorg. Chem. 1993, 32, 4277-4283.
80. Everett, J. R.; Davies, J. S.; Tyler, J. W. J. Chem. Soc. Perkin Trans. II 1986, 349-353.
81. (a) Suezawa, H.; Hashimoto, T.; Tsuchinaga, K.; Yoshida, T.; Yuzuri, T.; Sakakibara, K.; Hirota, M.; Nishio, M. J. Chem. Soc. Perkin Trans. 2 2000, 1243-1249.
82. (b) Evans, D. J.; Junk, P. C.: Smith. M. K. New J. Chem. 2002, 26, 1043-1048.
83. (a) Dugave, C.; Demange, L. Chem. Rev. 2003, 103, 2475-2532.
84. (b) Wróblewski, A. E.; Piotrowska, D. G. Tetrahedron 1998, 54, 8123-8132.
85. (c) Wallen, E. A. A.; Christiaans, J. A. M.; Gynther, J.; Vepsalainen, J. Tetrahedron Lett. 2003, 44, 2081-2082.
86. For a review see: (a) Santos, L. S.; Knaack, L.; Metzger, J. O. Int. J. Mass Spectrom. 2005, 246, 84-104.
87. (b) Eberlin, M. N. Eur. J. Mass Spectron. 2007, 13, 19-28.